Neuropsychological and Behavioral Testing in Young Patients With Cancer
Status: Recruiting
Phase: N/A
Diagnosis: Pediatric Brain Tumor
NCT ID: NCT00772200
(View complete trial on ClinicalTrials.gov)
DFCI Protocol ID: 08-363
This clinical trial is studying neuropsychological and behavioral testing in young patients with cancer. Collecting information over time from a series of tests may help doctors develop effective tests to measure neuropsychological and behavioral function in young patients with cancer.
Conducting Institutions:
Dana-Farber Cancer Institute, Children's Hospital Boston
Overall PI:
Peter Manley, MD,
Dana-Farber Cancer Institute
Site-responsible Investigators:
Contacts:
Dana-Farber Cancer Institute:
Childrens Hospital Pediatric Clinical Translation Investigation Program CTIP,
ctip@partners.org
Eligibility Criteria
DISEASE CHARACTERISTICS:
- Histologically confirmed diagnosis of medulloblastoma or supratentorial primitive
neuroectodermal tumor (PNET)
- Must be currently enrolled on COG-ACNS0331 or COG-ACNS0332 that aims to examine
neuropsychological, social, emotional, and/or behavioral functioning
PATIENT CHARACTERISTICS:
- Must have receptive and expressive English language skills
- No history of pre-existing neurodevelopmental disorder (e.g., traumatic brain injury,
mental retardation, or Down syndrome) prior to diagnosis of childhood cancer
- No history of birth weight < 1,500 g (associated with neuropsychological deficits)
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics